Non-Nucleoside Agonists of the Adenosine Receptors: An Overview
Potent and selective adenosine receptor (AR) agonists are of pharmacological interest for the treatment of a wide range of diseases and conditions. Among these derivatives, nucleoside-based agonists represent the great majority of molecules developed and reported to date. However, the limited availa...
Main Authors: | Diego Dal Ben, Catia Lambertucci, Michela Buccioni, Aleix Martí Navia, Gabriella Marucci, Andrea Spinaci, Rosaria Volpini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/12/4/150 |
Similar Items
-
Adenosine Receptor Agonists
by: Markus Wallner, et al.
Published: (2019-01-01) -
Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy
by: Nina Wolska, et al.
Published: (2019-11-01) -
Resistance of Muscle to Tumor Metastases: A Role for A3 Adenosine Receptor Agonists
by: Sara Bar-Yehuda, et al.
Published: (2001-01-01) -
Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases
by: Wiwin Is Effendi, et al.
Published: (2020-03-01) -
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?
by: Fabrizio Vincenzi, et al.
Published: (2020-12-01)